DATE: 07 April 2024 CATEGORY: PRESS RELEASE Ichnos Glenmark Innovation Presents Preclinical Data for its Oncology Asset ISB 2001 at AACR 2024 Annual Meeting - ISB 2001 is a first-in-class…
DATE: 08 March 2024 CATEGORY: PRESS RELEASE Ichnos Glenmark Innovation reports the publication in Nature Communications of the preclinical development of ISB 1442 bispecific antibody for Treatment of Relapsed/Refractory Multiple…
DATE: 30 Jan 2024 CATEGORY: PRESS RELEASE Ichnos and Glenmark take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance - ‘Ichnos Glenmark Innovation’ FOR IMMEDIATE RELEASE…
DATE: 12 Dec 2023 CATEGORY: PRESS RELEASE Ichnos Sciences Delivers Strong Evidence for its Trio of Oncology Assets at ASH 2023 Annual Meeting chnos presentations include clinical data on ISB…
